Latest Insider Transactions at Acadia Healthcare Company, Inc. (ACHC)
This section provides a real-time view of insider transactions for Acadia Healthcare Company, Inc. (ACHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Acadia Healthcare Company, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Acadia Healthcare Company, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 23
2022
|
John S. Hollinsworth EVP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
552
-0.6%
|
$37,536
$68.01 P/Share
|
|
Apr 11
2022
|
David M. Duckworth Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,128
+3.86%
|
-
|
|
Apr 11
2022
|
Christopher H. Hunter Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,521
+50.0%
|
-
|
|
Apr 11
2022
|
John S. Hollinsworth EVP of Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,043
+5.2%
|
-
|
|
Apr 11
2022
|
Christopher L Howard EVP, GC and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
4,693
+2.79%
|
-
|
|
Apr 11
2022
|
Laurence L. Harrod EVP of Finance |
BUY
Grant, award, or other acquisition
|
Direct |
4,466
+4.38%
|
-
|
|
Mar 24
2022
|
Laurence L. Harrod EVP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
2,600
-2.72%
|
$166,400
$64.48 P/Share
|
|
Mar 24
2022
|
Christopher L Howard EVP, GC and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,732
-1.69%
|
$174,848
$64.48 P/Share
|
|
Mar 24
2022
|
John S. Hollinsworth EVP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,802
-3.13%
|
$179,328
$64.48 P/Share
|
|
Mar 24
2022
|
David M. Duckworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,653
-2.12%
|
$169,792
$64.48 P/Share
|
|
Mar 07
2022
|
John S. Hollinsworth EVP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,967
-2.15%
|
$121,954
$62.21 P/Share
|
|
Mar 03
2022
|
Christopher L Howard EVP, GC and Secretary |
SELL
Bona fide gift
|
Indirect |
8,003
-8.55%
|
-
|
|
Mar 03
2022
|
Christopher L Howard EVP, GC and Secretary |
BUY
Bona fide gift
|
Direct |
8,003
+4.72%
|
-
|
|
Mar 02
2022
|
Christopher L Howard EVP, GC and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
801
-0.52%
|
$48,060
$60.64 P/Share
|
|
Mar 02
2022
|
David M. Duckworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
694
-0.55%
|
$41,640
$60.64 P/Share
|
|
Feb 25
2022
|
John S. Hollinsworth EVP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
23,653
-20.52%
|
$1,324,568
$56.92 P/Share
|
|
Feb 25
2022
|
John S. Hollinsworth EVP of Operations |
BUY
Grant, award, or other acquisition
|
Direct |
60,110
+34.27%
|
-
|
|
Feb 25
2022
|
Laurence L. Harrod EVP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
19,619
-17.01%
|
$1,098,664
$56.92 P/Share
|
|
Feb 25
2022
|
Laurence L. Harrod EVP of Finance |
BUY
Grant, award, or other acquisition
|
Direct |
55,761
+32.59%
|
-
|
|
Feb 25
2022
|
Christopher L Howard EVP, GC and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
12,506
-7.49%
|
$700,336
$56.92 P/Share
|
|
Feb 25
2022
|
Christopher L Howard EVP, GC and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
51,515
+23.57%
|
-
|
|
Feb 25
2022
|
David M. Duckworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,077
-13.76%
|
$1,124,312
$56.92 P/Share
|
|
Feb 25
2022
|
David M. Duckworth Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,022
+25.9%
|
-
|
|
Feb 25
2022
|
Debra K Osteen |
SELL
Payment of exercise price or tax liability
|
Direct |
118,075
-24.87%
|
$6,612,200
$56.92 P/Share
|
|
Feb 25
2022
|
Debra K Osteen |
BUY
Grant, award, or other acquisition
|
Direct |
300,066
+28.13%
|
-
|
|
Jan 31
2022
|
Debra K Osteen |
SELL
Payment of exercise price or tax liability
|
Direct |
27,403
-13.56%
|
$1,424,956
$52.31 P/Share
|
|
Aug 14
2021
|
John S. Hollinsworth EVP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,115
-1.98%
|
$68,015
$61.9 P/Share
|
|
Jun 14
2021
|
John S. Hollinsworth EVP of Operations |
SELL
Open market or private sale
|
Direct |
5,000
-8.16%
|
$330,000
$66.31 P/Share
|
|
Jun 14
2021
|
Reeve B Waud |
SELL
Open market or private sale
|
Indirect |
55,030
-5.02%
|
$3,631,980
$66.47 P/Share
|
|
May 06
2021
|
Vicky B Gregg |
BUY
Grant, award, or other acquisition
|
Direct |
2,550
+9.32%
|
-
|
|
May 06
2021
|
Michael Fucci |
BUY
Grant, award, or other acquisition
|
Direct |
2,550
+24.54%
|
-
|
|
May 06
2021
|
Reeve B Waud |
BUY
Grant, award, or other acquisition
|
Direct |
2,550
+8.26%
|
-
|
|
May 06
2021
|
Wade D Miquelon |
BUY
Grant, award, or other acquisition
|
Direct |
2,550
+5.51%
|
-
|
|
May 06
2021
|
Jason Bernhard |
BUY
Grant, award, or other acquisition
|
Direct |
2,550
+15.5%
|
-
|
|
May 06
2021
|
E. Perot Bissell |
BUY
Grant, award, or other acquisition
|
Direct |
2,550
+7.45%
|
-
|
|
May 06
2021
|
William M Petrie Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,550
+6.71%
|
-
|
|
May 06
2021
|
William Grieco |
BUY
Grant, award, or other acquisition
|
Direct |
2,550
+3.23%
|
-
|
|
May 02
2021
|
Christopher L Howard EVP, GC and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
956
-0.82%
|
$57,360
$60.92 P/Share
|
|
May 02
2021
|
David M. Duckworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
946
-0.99%
|
$56,760
$60.92 P/Share
|
|
Apr 23
2021
|
Christopher L Howard EVP, GC and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,477
+4.49%
|
-
|
|
Apr 23
2021
|
John S. Hollinsworth EVP of Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,620
+8.4%
|
-
|
|
Apr 23
2021
|
David M. Duckworth Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,320
+5.26%
|
-
|
|
Apr 23
2021
|
Laurence L. Harrod EVP of Finance |
BUY
Grant, award, or other acquisition
|
Direct |
5,213
+8.05%
|
-
|
|
Mar 24
2021
|
John S. Hollinsworth EVP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,802
-4.79%
|
$154,110
$55.02 P/Share
|
|
Mar 15
2021
|
William Grieco |
SELL
Open market or private sale
|
Direct |
2,000
-2.63%
|
$120,000
$60.65 P/Share
|
|
Mar 12
2021
|
William Grieco |
SELL
Open market or private sale
|
Direct |
2,000
-2.57%
|
$118,000
$59.02 P/Share
|
|
Mar 12
2021
|
Reeve B Waud |
SELL
Open market or private sale
|
Indirect |
109,443
-16.3%
|
$6,457,137
$59.12 P/Share
|
|
Mar 11
2021
|
Christopher L Howard EVP, GC and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
15,966
+6.94%
|
$351,252
$22.68 P/Share
|
|
Mar 11
2021
|
Christopher L Howard EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct |
33,228
-25.91%
|
$1,927,224
$58.09 P/Share
|
|
Mar 11
2021
|
David M. Duckworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,780
+5.09%
|
$319,260
$17.84 P/Share
|